Abstract
Objectives
Aim to analyze the effect of radiotherapy for cervical lymph node metastatic carcinoma with unknown primary (CCUP) and compare the survival benefits between Comprehensive radiotherapy and Involved Field radiotherapy.
Materials and methods
The patients diagnosed with CCUP between 2009 and 2019 in our institution were analyzed retrospectively. The categorical variables were tested by χ2 test. Kaplan–Meier method was used for survival analysis. Log-rank test and Cox proportional hazards regression were performed with overall survival (OS) and disease-free survival (DFS) as the primary outcome variables.
Results
Of 139 patients, 64.7% (90/139) of them received radiotherapy. Of the 90 patients who underwent radiotherapy, 45.6% (41/90) received Involved Field radiotherapy and the rest 49 patients received Comprehensive radiotherapy. The median follow-up of 139 patients is 69 months. The 1-year, 3-year, and 5-year OS rates are 87%, 62%, and 39%, respectively, and the DFS rates are 73%, 45%, and 29%, respectively. Multivariate analysis of 139 patients with CCUP shows that differentiation grade, N stage, radiotherapy, and the length of the largest lymph node (DmaxLN) are the independent prognostic factors for both OS and DFS. Subgroup analysis of 90 patients who received radiotherapy shows that the Comprehensive radiotherapy group has a better OS (P < 0.001) and DFS (P < 0.001) compared with Involved Field radiotherapy.
Conclusion
Radiotherapy is the independent prognostic factor for CCUP. Comprehensive radiotherapy may be superior to Involved Field radiotherapy in survival benefits.
Similar content being viewed by others
Availability of data and materials
The datasets generated analyzed during the current study are not publicly available.
Code availability
All statistical analyses were performed using R statistical software (version 4.0.1; http://www.r-project.org/), and the “survival” R package was used for survival analysis. The code can be obtained by contacting the corresponding author, with reasonable requests.
References
Arosio AD, Pignataro L, Gaini RM, Garavello W (2017) Neck lymph node metastases from unknown primary. Cancer Treat Rev 53:1–9. https://doi.org/10.1016/j.ctrv.2016.11.014
Bussu F, Sali M, Gallus R, Petrone G, Autorino R, Santangelo R, Pandolfini M, Miccichè F, Delogu G, Almadori G, Galli J, Sanguinetti M, Rindi G, Tommasino M, Valentini V, Paludetti G (2015) HPV and EBV infections in neck metastases from occult primary squamous cell carcinoma: another virus-related neoplastic disease in the head and neck region. Ann Surg Oncol 22(August):979–984. https://doi.org/10.1245/s10434-015-4808-5
Chen AM, Meshman J, Hsu S, Yoshizaki T, Abemayor E, John MS (2018) Oropharynx-directed ipsilateral irradiation for p16-positive squamous cell carcinoma involving the cervical lymph nodes of unknown primary origin. Head Neck 40(2):227–232. https://doi.org/10.1002/hed.24906
Cheol Park G, Roh J-LL, Cho K-JJ, Seung Kim J, Hyeon Jin M, Choi S-HH, Yuhl Nam S, Yoon Kim S (2017) 18F-FDG PET/CT vs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors. Int J Cancer 140(6):1405–1412. https://doi.org/10.1002/ijc.30550
Faquin WC (2014) Human papillomavirus (HPV) assays for testing fine-needle aspiration specimens in patients with head and neck squamous cell carcinoma. Cancer Cytopathol 122(2):92–95. https://doi.org/10.1002/cncy.21374
Galloway TJ, Ridge JA (2015) Management of squamous cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol 33(29):3328–3337. https://doi.org/10.1200/JCO.2015.61.0063
Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB (2000) Cervical lymph node metastases from unknown primary tumours: results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 55(2):121–129. https://doi.org/10.1016/S0167-8140(00)00172-9
Jannapureddy S, Cohen C, Lau S, Beitler JJ, Siddiqui MT (2010) Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases. Diagn Cytopathol 38(11):795–800. https://doi.org/10.1002/dc.21293
Jereczek-Fossa BA, Jassem J, Orecchia R (2004) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 30(2):153–164. https://doi.org/10.1016/j.ctrv.2003.10.001
Ligey A, Gentil J, Créhange G, Montbarbon X, Pommier P, Peignaux K, Truc G, Maingon P (2009) Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiother Oncol 93(3):483–487. https://doi.org/10.1016/j.radonc.2009.08.027
Lu X, Hu C, Ji Q, Shen C, Feng Y (2009) Squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: the impact of radiotherapy. Tumori 95(2):185–190
Mălin RD, Ioniţă E, Osman I, Mogoantă CA, Cioroianu L, Ciolofan S, Anghelina F, Enăchescu M, Mǎlin RD, Ioniţǎ E, Osman I, Mogoantǎ CA, Cioroianu L, Ciolofan S, Anghelina F, Enǎchescu M (2012) Histopathological and immunohistochemical study of laterocervical lymph node metastases of unknown primary origin. Rom J Morphol Embryol 53(2):337–342
Martin JM, Galloway TJ (2015) Evaluation and management of head and neck squamous cell carcinoma of unknown primary. Surg Oncol Clin N Am 24(3):579–591. https://doi.org/10.1016/j.soc.2015.03.007
Mizuta M, Kitamura M, Tateya I, Tamaki H, Tanaka S, Asato R, Shinohara S, Takebayashi S, Maetani T, Kitani Y, Kumabe Y, Kojima T, Ushiro K, Ichimaru K, Honda K, Yamada K, Omori K (2018) Unknown primary squamous cell carcinoma of the head and neck: retrospective analysis of 80 cases. Acta Otolaryngol 138(6):590–596. https://doi.org/10.1080/00016489.2017.1422141
Motz K, Qualliotine JR, Rettig E, Richmon JD, Eisele DW, Fakhry C (2016) Changes in unknown primary squamous cell carcinoma of the head and neck at initial presentation in the era of human papillomavirus. JAMA Otolaryngol Head Neck Surg 142(3):223–228. https://doi.org/10.1001/jamaoto.2015.3228
Pavlidis N, Pentheroudakis G, Plataniotis G (2009) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP. Clin Transl Oncol 11(6):340–348. https://doi.org/10.1007/s12094-009-0367-1
Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ et al (2020) Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN 18(7):873–898. https://doi.org/10.6004/jnccn.2020.0031
Pflumio C, Troussier I, Sun XS, Salleron J, Petit C, Caubet M, Beddok A, Calugaru V, Servagi-Vernat S, Castelli J, Miroir J, Krengli M, Giraud P, Romano E, Khalifa J, Doré M, Blanchard N, Coutte A, Dupin C et al (2019) Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study. Eur J Cancer 111:69–81. https://doi.org/10.1016/j.ejca.2019.01.004
Poon WY, Thomson M, McLoone P, Wilson C, Crosbie R, Schipani S, Grose D, James A, Lamb C, Rizwanullah M, Campbell F, Easton F, Paterson C (2020) Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck—Involved neck only versus mucosal irradiation. Clin Otolaryngol 45(6):847–852. https://doi.org/10.1111/coa.13593
Reddy SP, Marks JE (1997) Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys 37(4):797–802. https://doi.org/10.1016/s0360-3016(97)00025-4
Schroeder L, Boscolo-Rizzo P, Dal Cin E, Romeo S, Baboci L, Dyckhoff G, Hess J, Lucena-Porcel C, Byl A, Becker N, Alemany L, Castellsagué X, Quer M, León X, Wiesenfarth M, Pawlita M, Holzinger D (2017) Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: a retrospective multicentre study. Eur J Cancer 74:73–81. https://doi.org/10.1016/j.ejca.2016.12.020
Straetmans JMJAA, Stuut M, Wagemakers S, Hoebers F, Kaanders JHAM, Speel EJM, Melchers WJG, Slootweg P, Kremer B, Lacko M, Takes RP (2020) Tumor control of cervical lymph node metastases of unknown primary origin: the impact of the radiotherapy target volume. Eur Arch Otorhinolaryngol 277(6):1753–1761. https://doi.org/10.1007/s00405-020-05867-2
Strojan P, Ferlito A, Langendijk JA, Corry J, Woolgar JA, Rinaldo A, Silver CE, Paleri V, Fagan JJ, Pellitteri PK, Haigentz MJ, Suárez C, Robbins KT, Rodrigo JP, Olsen KD, Hinni ML, Werner JA, Mondin V, Kowalski LP et al (2013) Contemporary management of lymph node metastases from an unknown primary to the neck: II a review of therapeutic options. Head Neck 35(2):286–293. https://doi.org/10.1002/hed.21899
Tang L, Wei F, Wu Y, He Y, Shi L, Xiong F, Gong Z, Guo C, Li X, Deng H, Cao K, Zhou M, Xiang B, Li X, Li Y, Li G, Xiong W, Zeng Z (2018) Role of metabolism in cancer cell radioresistance and radiosensitization methods. J Exp Clin Cancer Res 37(1):87. https://doi.org/10.1186/s13046-018-0758-7
Wang Y, He S-SS, Bao Y, Cai X-YY, Chen H-YY, Yang X-LL, Chen D-MM, Lu L-XX, Chen Y (2018) Cervical lymph node carcinoma metastasis from unknown primary site: a retrospective analysis of 154 patients. Cancer Med 7(5):1852–1859. https://doi.org/10.1002/cam4.1458
Zhou MJ, van Zante A, Lazar AA, Groppo ER, Garsa AA, Ryan WR, El-Sayed IH, Eisele DW, Yom SS (2018) Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer. Head Neck 40(5):904–916. https://doi.org/10.1002/hed.25028
Funding
This study was funded by the National Natural Science Foundation of China (81672386 and 81402494), the Sichuan Province Science and Technology Support Program (No. 2021YFSY008), and the technology Innovation Project of Chengdu Science and Technology Bureau (No. 2019-YF05-00459-SN).
Author information
Authors and Affiliations
Contributions
Conceptualization and funding acquisition: XP; methodology and resources: XP, LH, and RL; data curation: RL, LH, XM, and LY; software and formal analysis: RL, KL, and YH; supervision and investigation: RL, ZW, and KL; validation: RL, ZL, and JW; visualization: RL, ZW, and YH; writing—original draft and writing—review and editing: RL, KL, and LH; project administration: XP and LH.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This retrospective study complies with the ethical standards of the institution, and follows the principles of the Helsinki Declaration. Approval was granted by the Ethics Committee of West China Hospital of Sichuan University.
Consent to participate
Because of the retrospective nature of this study, consent to participate for inclusion was waived.
Consent to publish
Because of the retrospective nature of this study, consent to publish was waived.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Li, R., Liao, K., Wei, Z. et al. The prognostic role of radiotherapy and radiotherapy target in cervical lymph node metastatic squamous cell carcinoma with unknown primary: a retrospective study. J Cancer Res Clin Oncol 148, 1437–1445 (2022). https://doi.org/10.1007/s00432-021-03724-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-021-03724-1